Clinical Trial

SIRT Versus cTACE for Unresectable HCC (CHANCE2506)

Name: SIRT Versus cTACE for Unresectable HCC (CHANCE2506) — clinical trial record (NCT06909708)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of yttrium-90 carbon microspheres versus cTACE in patients with unresectable hepatocellular carcinoma

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-03-26.

Status change: Not Yet Recruiting → Recruiting 2025-04-06

Trial Details

NCT Number	NCT06909708
Lead Sponsor	Zhongda Hospital
Conditions	Unresectable Hepatocellular Carcinoma
Enrollment	108 participants
Start Date	2025-04-03
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-01-30 (estimated)
Updated on ClinicalTrials.gov	2025-04-09